When someone is acting oddly, it is often said that she or he is "is not herself" or not "himself". This generally refers to a change is personality, either due to distraction, stress or some other emotional alteration. During the past decade, a new interpretation of this statement has arisen. This relates to the contribution of immunity to a variety of common, chronic diseases.
The concept of self, when used in the context of immunity has a very different connotation compared to its use above. A fundamental property of immunity is to recognize non-self, and to protect self. This is an extremely primitive response, present in single cells organisms, prokaryocytes and non-vertebrates. For example, bacteria contain restriction endonuclease enzymes, now commonly used as tools for molecular biology research, that chop up DNA of viruses, but not their own DNA. Sponges, which evolved during the metazoan period, possess the capacity to engulf bacteria into specific cells, display signaling responses to bacterial products and produce reactive oxygen species (ROS) and NO to kill foreign organisms (6).
Sponges will not graft with those of other species, but will readily form allografts with sponges of the same species (24) .
Based on these considerations, diseases have been dichotomously classified as "autoimmune" and "everything else". The classic autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, psoriasis, systemic sclerosis, Sjogren's syndrome, vasculitides and inflammatory bowel diseases are unique, unfortunate conditions in which the immune system fails to recognize self, attacks various tissues leading to severe, life-threatening pathology. These disorders often respond to immune suppression and new therapies have been developed that modulate, but do not entirely suppress the immune response, which have been used successfully to treat these conditions. The problem with this simple division of diseases is that it is overly simplistic. Cells of the innate and adaptive immune system show up in various tissues affected by diseases not traditionally viewed as autoimmune. As an example, we have known that cells of both the innate and adaptive immune system are present in atherosclerotic lesions of humans for more than a century and a half (8) . This isn't terribly surprising, because monocytes and lymphocytes travel in and out of tissues as part of immune surveillance, and these cells might be simply "cleaning up" diseased cells or walling off an inflammatory process. In the last three decades, however, it has become clear that these cells are activated and are releasing mediators, or cytokines, that contribute to the disease process (11) . Studies of mice with experimental atherosclerosis have revealed that these T cells and their mediators contribute to lesion formation. More recently, the adaptive immune system has been implicated in experimental hypertension. T cells and macrophages infiltrate the vasculature and kidneys of hypertensive mice and rats and contribute to blood pressure elevation in these models (12) . These cells also accumulate in adipose tissues of overweight humans and animals (27) , and seem to contribute to insulin intolerance, atherosclerosis, endothelial dysfunction and dyslipidemia that accompany obesity (19) . T cell activation and cytokines contribute to bone loss caused by estrogen deficiency (10) . Microglial cells, which are resident macrophages of the brain, are activated in hypertension and over nutrition (21, 26 ).
There are also numerous instances where immune-mediated diseases overlap with non-immune diseases.
As an example, it has recently been shown that asthmatics have more than a 2-fold increase type 2-diabetes and about a 1.5 fold increase in coronary artery disease (28) . Cardiovascular diseases such as hypertension and coronary artery disease are increased among subjects with SLE, psoriasis and rheumatoid arthritis (3, 16, 7) .
Why do cells designed to protect us against disease begin to attack our vessels, our kidney, bones, liver and brain to promote chronic diseases such as hypertension, atherosclerosis, diabetes and osteoporosis? An attractive paradigm is that in these conditions, initial triggers alter endogenous molecules such that they are no longer recognized as "self". This could involve extracellular release of proteins or other molecules that are generally intracellular, post-translational modification of endogenous molecules, cleavage of proteins to expose intramolecular sites normally not available for immune recognition, or by attachment of an unusual epitope to a molecule in a hapten-like fashion. Immunoreactive molecules such as these have been found in the serum of humans with cancer (5), in inflammatory diseases such as halothane-induced hepatitis (15) , in patients with glomerulonephritis (25), and in the setting of osteoarthritis (14) . Molecules proposed to cause immune responses in atherosclerosis include oxidized LDL, heat shock proteins, platelet glycoproteins and others, although no specific antigen has been identified with certainty (9).
There are two predominant theories to explain how these altered molecules, no longer recognized as self, produce disease. One concept is that these serve as new ligands for various pattern recognition receptors that promote innate immune responses. An example is activation of toll-like receptors (TLRs) by modified lipoproteins, heat shock proteins, fibronectin and breakdown products of the extracellular matrix. Oxidized lipoproteins activate TLR4 in a manner similar to bacterial coat proteins (22, 18) . TLR ligation activates NFκB leading to production of myriad cytokines, chemokines and molecules involved in T cell costimulation. TLR ligation on T cells and dendritic cells directs T cell polarization that in turn has long lasting effects on the inflammatory milieu (23) . A second theory as to why modified "self" molecules cause disease is that they serve as neoantigens. This is less well understood, but post-translationally modified proteins can be processed by antigen presenting cells and activate CD4+T cells (13) . Oxidatively modified proteins, taken up by scavenger receptors of macrophages can activate CD4+ cells (20) , and adoptive transfer of CD4+ cells activated in this fashion aggravates atherosclerosis in ApoE These require orchestrated signals from peripheral tissues, secondary lymphoid organs, the bone marrow, the vasculature and the central nervous system. Second, this topic is clearly important. The concept that many chronic diseases such as atherosclerosis, osteoporosis, hypertension and obesity are in part caused by smoldering autoimmunity represents a paradigm shift in understanding human disease and systems biology.
Third, there has been enormous growth in our understanding of immunology, and new animals models, assays and tools have made it possible to study other fields in substantial depth not previously possible.
Finally, we clearly need additional information about this topic. We don't understand the biochemical, physical and molecular changes are that activate the immune system in these conditions and how to stop this shift from "self" to "non-self". Better comprehension of this topic could lead to specific therapies that would either halt this shift or modify the immune responses that promote disease. We hope that this call for papers begins to fill some of these needs or will spur the further work in this direction by talented integrative physiologists.
